Since its discovery more than 25 years ago, the kinase AKT has become a central figure in cell signaling. We highlight some of the landmark findings in those 25 years that contributed to our understanding of the regulation and function of AKT in directing cellular processes and behavior. Future progress toward fully understanding the roles of AKT in cell, tissue, and organismal biology will depend on technological innovations and the combination of in-depth reductionist analyses with systems-based strategies.
In the course of studies focusing on the factors responsible for the induction of thymomas in AKR mice, Staal et al. isolated in 1977 the acute transforming retrovirus AKT8 (1) . Thirteen years later, it was shown that the oncogene transduced by this virus encodes a serine/threonine protein kinase (AKT) (also known as PKB), which harbors an N-terminal regulatory domain (now known as the PH domain) and exhibits a high degree of homology with the kinases PKC and PKA (2) (3) (4) (5) . Soon after its discovery, it became evident that the AKT kinase, which has three closely related but functionally distinct isoforms encoded by paralogous genes (6), defines a critical node in the network of cell signaling and that its deregulation gives rise to multiple diseases, including cancer and metabolic, neuropsychiatric, degenerative, and immune dysfunction-associated diseases.
The observation that placed AKT in center stage came a few years after its initial discovery, when it was shown that its activation by external signals depends on phosphatidylinositol 3-kinase (PI3K)-generated phosphoinositides and that the process of activation is PH domain-dependent (7). Linking AKT activation to PI3K-generated phosphoinositides via the PH domain not only identified AKT as the first bona fide PI3K target but also identified a novel protein domain that relays PI3K-transduced signals. Defining the function of the PH domain, in turn, led to the identification and characterization of a multitude of PI3K-dependent signaling molecules.
Today, we know that the abundance of PI3K-generated D3-phosphorylated phosphoinositides depends, in addition to PI3K, on several phosphoinositide-modifying enzymes, including the phosphatases PTEN, SHIP, and INPP4B and the kinases PIP4K, PIP5K, PIK3C2A, and IP6K1, and that these enzymes also contribute to AKT regulation. In addition, we know that the binding of the PH domain of AKT to membrane-associated PI(3,4)P 2 and PI(3,4,5)P 3 , which are induced via PI3K activation, is required for the translocation of AKT to the membrane, where it is activated via T loop phosphorylation (Thr   308   ) by phosphoinositide-dependent kinase 1 (PDK1) (8) and hydrophobic motif phosphorylation (Ser
473
) by mammalian target of rapamycin complex 2 (mTORC2) (9) . In addition to illuminating the mechanism of AKT activation by external signals, this work generated a blueprint for deciphering the mechanism of activation of other PH domain-containing kinases.
The discovery of these basic aspects of AKT regulation, followed by the discovery of a multitude of AKT targets, linked AKT to major signaling networks that control membrane, cytoplasmic, organellar, nuclear, and cytoskeletal activity. This work is the subject of more than 60,000 publications over the last 25-plus years, linking the PI3K-AKT pathway to cell, tissue, and organismal biology.
Despite significant progress to date, important questions on the regulation and function of AKT remain. Some of these questions relate to the topology of AKT activation, which have not been addressed adequately because of technological limitations. Such questions include, but are not limited to, the mechanism(s) by which external signals promote the rapid transport of AKT to the membrane, where it is anchored by binding to D3-phosphorylated phosphoinositides; the mechanism(s) coordinating AKT phosphorylation at Thr 308 and Ser 473 by kinases that may be localized in different cellular membranes (PDK1 in the plasma membrane and mTORC2 in the endoplasmic reticulum) (8, 10); the mechanism(s) by which AKT activated in cellular membranes reaches its targets in different cellular compartments; and the mechanism(s) by which AKT may be activated directly in endomembranes in different subcellular locations.
Other outstanding questions relate to the complexity of AKT signaling and biological systems where AKT is operating. Such questions focus on the mechanism(s) responsible for the differences between AKT isoforms and the biological importance of these differences in complex biological systems, such as cancer, the complexity of AKT posttranslational modifications and their biological output (Fig. 1) , and the complexity emerging from the integration of AKT signals with the cellular signaling landscape. This complexity is likely to be responsible for the fact that the predicted impact of targeting AKT in cancer and other human diseases is, as yet, an unfulfilled promise. Future success of AKT-targeted therapies will depend on the imaginative application of new research tools that combine in-depth reductionist analyses and systems-based strategies.
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